CDXS – codexis, inc. (US:NASDAQ)
Stock Stats
News
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics [Yahoo! Finance]
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics [Yahoo! Finance]
Form SCHEDULE 13G/A CODEXIS, INC. Filed by: Nantahala Capital Management, LLC
Form 4 CODEXIS, INC. For: Nov 07 Filed by: De Vre Raymond
Form 3 CODEXIS, INC. For: Nov 07 Filed by: De Vre Raymond
Form 8-K CODEXIS, INC. For: Nov 07
Form 10-Q CODEXIS, INC. For: Sep 30
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.